Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Deerfield Management Picks From 2015 Show SIgns Of Life This Year.

|Includes: AveXis (AVXS), EDIT, HZNP, JUNO, SHPG

Well known healthcare investors, Deerfield Mgmt, have invested some $550M into newly public companies in the last year or so. They have $5B AUM and have picked up private shares very early on in Philly based Spark Therapeutics (NASDAQ:ONCE). It seem that Deerfield's raw picks peaked last year in Q1, but have begun to turn it around this year.

ONCE Chart

ONCE data by YCharts

Usually the early stage investing is left to their innovation fund, but Deerfield also backed Juno Therapeutics (NASDAQ:JUNO) a top pick across analyst boards due to its raw potential.

KITE Chart

KITE data by YCharts

As of late, James Flynn has gotten solid returns from his IPO cohorde with Editas (NASDAQ:EDIT) (5% stake)and AveXis (NASDAQ:AVXS) (10% stake). This followed his trend from last year where he made a killing in Global Blood Therapeutics (NASDAQ:GBT) IPO (3.7% stake).

EDIT Chart

EDIT data by YCharts

Needless to say, Deerfield is a top healthcare fund to watch if you want to find where smart money is getting returns in this sector.

TOP POSITIONS INCLUDE: (MYL, SHPG, HZNP, GSK, FPRX, CRL)

Disclosure: I am/we are long ONCE, EDIT, GBT.